Outset Medical Stock News

Outset Medical (NASDAQ:OM) is scheduled to announce Q4 earnings results on Wednesday, February 16th, after market close.The consensus EPS Estimate is -$0.67 (-11.7% Y/Y) and the…

This stock has a market cap of close to $2 billion and a market opportunity of more than $11 billion per year.

If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 100 hour timeframe. The post Outset Medical Inc (OM): Price Now Near $43.12; Daily Chart Shows Downtrend on 50 Day Basis appeared first on ETF Daily News .

DekaBank Deutsche Girozentrale grew its holdings in Outset Medical, Inc. (NASDAQ:OM) by 700.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,000 shares of the companys stock after purchasing an additional 17,500 shares during the period. DekaBank Deutsche Girozentrales holdings in []

NEXT Financial Group Inc lifted its stake in Outset Medical, Inc. (NASDAQ:OM) by 47.3% during the third quarter, Holdings Channel.com reports. The fund owned 4,162 shares of the companys stock after buying an additional 1,336 shares during the period. NEXT Financial Group Incs holdings in Outset Medical were worth $206,000 as of its most recent []

The FDA has granted 510(k) clearance for Outset Medical Inc''s (NASDAQ: OM ) new sterilization method of the cartridge utilized in its Tablo Hemodialysis System, enabling full production in North America. The Tablo cartridge is a single-use disposable that works in concert with the console to Full story available on Benzinga.com

The FDA has granted 510(k) clearance for Outset Medical Inc's (NASDAQ: OM) new sterilization method of the cartridge utilized in its Tablo Hemodialysis System, enabling full production in North Am

The stock price of Outset Medical Inc (NASDAQ: OM) increased by over 5% after hours today. This is why it happened.

Equities research analysts expect Outset Medical, Inc. (NASDAQ:OM) to report earnings of ($0.67) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Outset Medicals earnings, with estimates ranging from ($0.71) to ($0.62). Outset Medical posted earnings of ($0.60) per share during the same quarter last year, which would []

Schonfeld Strategic Advisors LLC reduced its stake in shares of Outset Medical, Inc. (NASDAQ:OM) by 68.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,868 shares of the companys stock after selling 10,532 shares during the quarter. Schonfeld Strategic Advisors LLCs holdings []

Weiss Multi Strategy Advisers LLC boosted its holdings in Outset Medical, Inc. (NASDAQ:OM) by 53.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,217 shares of the companys stock after acquiring an additional 5,269 shares during the quarter. Weiss Multi []

The consensus price target hints at a 27.4% upside potential for Outset Medical, Inc. (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earning

Outset Medical, Inc. (OM) Leslie Trigg on Q3 2021 Results - Earnings Call Transcript

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of 9.23% and 4.73%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?